About Us

Ultragenyx is a privately held, developmental stage biotechnology company committed to bringing life-enhancing therapeutics for patients with rare and ultra-rare genetic diseases, also known as orphan diseases, to market. The company focuses on metabolic and rare diseases that may affect small numbers of patients, but for which the medical need is high and there are no effective treatments. Ultragenyx intends to build a sustainable pipeline of safe and effective therapies to address these clinically underserved diseases.

February 2012 Ultragenyx Corporate Presentation

News

May 1, 2012
Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare, Neuromuscular Disease. Click here for the related press release.

April 23, 2012
Ultragenyx Relocates Company Headquarters to Support Operational Expansion. Click here for the related press release.

Careers

If you are interested in applying for a position with Ultragenyx, please submit your cover letter and resume to HR@ultragenyx.com. Due to the volume of applications we receive, you will only be contacted if your background and experience best matches the requirements we are seeking. Click on the Careers link for a list of open positions.